FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured

NCT01062022 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2016-08-18

No results posted yet for this study

Summary

The purpose of this study is to implement a unique evidence-based intervention program to help military families deal with the critical issue of combat injury and its impact on current and future family health and functioning. The study is a randomized study. The study will compare the effects of the newly designed FOCUS-CI (Families OverComing Under Stress - Combat Injury) with the existing standard of care (SoC) at three military medical rehabilitation sites (Walter Reed Amry Medical Center, Brooke Army Medical Center and Madigan Army Medical Center) on key aspects of family health and functioning.

Conditions

  • Stress Disorders
  • Combat Disorders
  • Traumatic Stress Disorders

Interventions

BEHAVIORAL

Standard of Care

Families randomized to this arm will receive the standard of care. They will be compared to the families in the FOCUS-CI arm of the study.

BEHAVIORAL

FOCUS-CI

Families randomized to this arm of the study will be part of a family skill-building/resiliency training program designed to provide information and skills training

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    collaborator FED
  • Henry M. Jackson Foundation for the Advancement of Military Medicine

    lead OTHER

Principal Investigators

  • Stephen Cozza, MD · Uniformed Services University of the Health Sciences (USUHS)

  • Robert Ursano, MD · Uniformed Services University of the Health Sciences (USUHS)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01062022 on ClinicalTrials.gov